Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
annum, arising, AU, BioMed, book, breast, converted, convertible, Edinburgh, embedded, exert, experienced, feature, forin, freestanding, GAAP, halt, loan, lymphoproliferative, Master, millionfor, MPI, Oversight, paragraph, RESULTSOF, retrospectively, Roslin, Scotland, SEC, Smithfield, sublicense, suspended, unpaid, ViaGen, worldwide
Removed:
bear, minimal, redeemed, refused, rigorously, Roche, unilateral, wind
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 4.1 Convertible Promissory Note, Between Geron Corporation and Viagen, Inc.
- 10.1 Loan Agreement, Between Geron Corporation and Viagen, Inc.
- 31.1 Certification of Chief Executive Officer Pursuant to Form of Rule 13A-14(A)
- 31.2 Certification of Chief Financial Officer Pursuant to Form of Rule 13A-14(A)
- 32.1 Certification of Chief Executive Officer Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification of Chief Financial Officer Pursuant to 18 U.s.c. Section 1350
Related press release
GERN similar filings
Filing view
External links